Northwell Health Earns Care Delivery Award from Telehealth Leader Amwell

Northwell Health has been recognized by national telehealth leader Amwell® (NYSE: AMWL) with its New Models, New Normal Award. The distinction went to organizations nationwide that demonstrated outstanding achievements in adapting care delivery models to respond to rapidly changing health care circumstances.

Northwell, New York State’s largest health system and private employer, rapidly scaled up its telehealth offerings as it faced the coronavirus disease 2019 (COVID-19) pandemic, witnessing an unprecedented 5,031 percent expansion in usage between February 2020 and February 2021. Those telehealth visits, powered by Amwell technology, were conducted across 85 departments using the integrated direct-to-patient platform.

“Northwell has been a true virtual care pioneer and has long led the way in developing innovative care delivery models to best meet the needs of their providers, care teams and patients,” said Dan Olson, senior vice president of Customer Solutions at Amwell. “From using telehealth to support its ambulatory and behavioral health programs to deploying telemedicine devices to expand specialty consultations across trauma, oncology, toxicology, PICU/NICU and more, Northwell continues to blaze new trails on what’s possible with virtual and hybrid care models. We are excited to continue to partner with the Northwell team as they further expand telehealth programs/services throughout their organization to meet the needs of their communities and patients.”

Patient consults were performed through 130 telemedicine carts deployed across Northwell emergency rooms, facilities, and affiliated locations. The health system also adapted existing telehealth programs to meet the new needs brought on by COVID-19 restrictions. For example, its TeleSNF program for skilled nursing facilities (SNF) not only helped connect specialty providers to those care teams, it also virtually brought family visits into the SNF. Northwell’s existing telepsychiatry program supported the COVID-19 transfer center and expanded to cover emergency room psychiatry during the pandemic.

“The onset of the COVID-19 crisis in New York tested every aspect and individual involved in delivering care to our communities,” said Martin Doerfler, MD, senior vice president of clinical strategy and development at Northwell Health. “Northwell is incredibly proud of how the telehealth teams responded to provide the tools and support to all of our clinicians and patients as they dealt with the crisis and much appreciated the support of the Amwell team in our efforts.”

During 2020 alone, the health system added more than 8,000 clinicians, nurses, office managers onto the Amwell system to conduct virtual visits. The effort allowed patients to get immediate care while limiting staff exposure during the height of the pandemic. Northwell treated more than 163,000 COVID-19 patients in the span of a year, more than anyone else.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version